Prot #EB01-ABH001: A Multicenter, Prospective, Randomized, Open-label, Intra-patient Controlled Study of the Efficacy and Safety of ABH001 for the Treatment of Stalled Chronic Cutaneous Wounds Associated with Generalized Epidermolysis Bullosa

Project: Research project

Project Details

StatusFinished
Effective start/end date12/19/12 → 12/19/15

Funding

  • PRA Health Sciences (Prot #EB01-ABH001 // Prot #EB01-ABH001)
  • Shire Regenerative Medicine, Inc. (Prot #EB01-ABH001 // Prot #EB01-ABH001)